glp-1 dementia study Penn Holderness, a family influencer, has the highest genetic risk for Alzheimer's. He started taking a solely to prevent it, but experts say the research is still emerging. See link below An analysis on the role
Description
Up to 90% of participants on tirzepatide achieved an A1C of less than 7%
No blinding was used in the initial mouse study, though the CROs conducting the second mouse study and the NHP study were blinded to the antibodies we supplied
Research and development of safe and effective anti-obesity pharmacotherapies is urgently needed considering the current obesity epidemic
The "52-week window" refers to the timeframe of the Hansen et al
